Docola, Inc. (DOCO)
Docola will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$5.75 - $6.75
Shares Offered
1,165,217
Deal Size
$7.28M

Company Description

Docola aims to be a social good organization offering a free care communication platform that seeks to consolidate thousands of free and low-cost patient education resources from the leading nonprofit, government, and commercial organizations in one online marketplace called Docola.

Additionally, our Platform allows users to easily create and upload their own resources. With the use of our Platform, clinicians and patient-facing professionals can ePrescribe personalized information to an individual patient or groups of patients.

Patients can review the information and ask questions in the comfort of their own homes before, between, or after in-person or virtual visits.

We aim to enable healthcare providers to proactively meet people’s health informational needs, so they understand why it is important, possible, and safe to participate in their own medical care.

We aim to save time both for the patient and provider and improve patient satisfaction and patient outcomes.

To support the free version of the Platform, we offer optional paid services and license a separate product called DocolaRx, to research organizations, medical devices, biotech and pharmaceutical companies for their projects.

Docola, Inc.
CountryUnited States
Founded2013
IndustryInternet Content & Information
SectorCommunication Services
Employees1
CEOEran Kabakov

Contact Details

Address:
801 W. Bay Drive #506
Largo, FL 33770
United States
Phone(888) 981-8111
Websitedoco.la

Stock Details

Ticker SymbolDOCO
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001644515
Employer ID46-3626795
SIC Code7374

Key Executives

NamePosition
Eran KabakovChief Executive Officer, President
Itay TsabariChief Financial Officer
Tomer KabakovChief Operating Officer and Director
Jonathan AscherChief Medical Officer
Geri Lynn BaumblattChief Engagement Officer
Alexander EllisChief Technology Officer
Virginia SmithIndependent Director
Jean Anne BoothIndependent Director
Prasad TareIndependent Director

Latest SEC Filings

DateTypeTitle
Aug 28, 2024S-1/A[Amend] General form for registration of securities under the Securities Act of 1933
Jul 18, 2024S-1/A[Amend] General form for registration of securities under the Securities Act of 1933
Jun 20, 2024S-1/A[Amend] General form for registration of securities under the Securities Act of 1933
May 13, 2024S-1/A[Amend] General form for registration of securities under the Securities Act of 1933
Feb 1, 2024S-1/A[Amend] General form for registration of securities under the Securities Act of 1933
Jan 2, 2024S-1/A[Amend] General form for registration of securities under the Securities Act of 1933
Dec 21, 2023S-1/A[Amend] General form for registration of securities under the Securities Act of 1933
Dec 20, 20238-A12BRegistration of securities
Nov 20, 2023S-1/A[Amend] General form for registration of securities under the Securities Act of 1933
Oct 10, 2023S-1General form for registration of securities under the Securities Act of 1933